Neuromodulation is "the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body". It is carried out to normalize – or modulate – nervous tissue function. It is divided into invasive and non-invasive neuromodulation, which includes ETC, Transcranial Electrical Stimulation (tES) and so on.

Report Overview

Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.

The USA market for Non-invasive Neuromodulation Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The China market for Non-invasive Neuromodulation Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The Europe market for Non-invasive Neuromodulation Device is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.

The global key manufacturers of Non-invasive Neuromodulation Device include Neuroelectrics, Magstim, NeuroCare Group, Soterix Medical, Newronika, Rogue Resolutions, Medtronic, Philips Healthcare and Shenzhen Yingchi Technology, etc. In 2021, the global top five players had a share approximately % in terms of revenue.

Report Scope

This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers' production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Non-invasive Neuromodulation Device manufacturers, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases.

This report also includes a discussion of the major players across each regional Non-invasive Neuromodulation Device market. Further, it explains the major drivers and regional dynamics of the global Non-invasive Neuromodulation Device market and current trends within the industry.

Key Companies Covered

In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:

Neuroelectrics

Magstim

NeuroCare Group

Soterix Medical

Newronika

Rogue Resolutions

Medtronic

Philips Healthcare

Shenzhen Yingchi Technology

Shenzhen Hanix United

Shanghai Qiankang Medical Care Company

TCT Research

EB Neuro SpA

Market Segments

This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.

Non-invasive Neuromodulation Device Segment by Type

Transcranial Direct Current Stimulation (tDCS)

Transcranial Alternating Current Stimulation (tACS)

Transcranial Pulsed Current Stimulation (tPCS)

Transcranial Random Noise Stimulation (tRNS)

Electroconvulsive therapy (ECT)

Others

Non-invasive Neuromodulation Device Segment by Application

Hospital

Clinic

Others

Key Regions & Countries

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Non-invasive Neuromodulation Device market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Report Includes:

This report presents an overview of global market for Non-invasive Neuromodulation Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.

This report researches the key producers of Non-invasive Neuromodulation Device, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Non-invasive Neuromodulation Device, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Non-invasive Neuromodulation Device sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Non-invasive Neuromodulation Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Non-invasive Neuromodulation Device sales, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Neuroelectrics, Magstim, NeuroCare Group, Soterix Medical, Newronika, Rogue Resolutions, Medtronic, Philips Healthcare and Shenzhen Yingchi Technology, etc.

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Non-invasive Neuromodulation Device Market Size Growth Rate by Type (2017 VS 2021 VS 2028)

1.2.2 Transcranial Direct Current Stimulation (tDCS)

1.2.3 Transcranial Alternating Current Stimulation (tACS)

1.2.4 Transcranial Pulsed Current Stimulation (tPCS)

1.2.5 Transcranial Random Noise Stimulation (tRNS)

1.2.6 Electroconvulsive therapy (ECT)

1.2.7 Others

1.3 Market Segment by Application

1.3.1 Global Non-invasive Neuromodulation Device Market Share by Application (2017 VS 2021 VS 2028)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Non-invasive Neuromodulation Device Market Size (2017-2028)

2.1.1 Global Non-invasive Neuromodulation Device Revenue (2017-2028)

2.1.2 Global Non-invasive Neuromodulation Device Sales (2017-2028)

2.2 Global Non-invasive Neuromodulation Device Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028

2.2.1 Global Non-invasive Neuromodulation Device Sales by Regions (2017-2022)

2.2.2 Global Non-invasive Neuromodulation Device Revenue by Regions (2017-2022)

2.3 Global Non-invasive Neuromodulation Device Market Size Forecast by Region

2.3.1 Global Non-invasive Neuromodulation Device Sales Forecast by Region (2023-2028)

2.3.2 Global Non-invasive Neuromodulation Device Revenue Forecast by Region (2023-2028)

2.4 Global Top Non-invasive Neuromodulation Device Regions (Countries) Ranking by Market Size

2.5 Non-invasive Neuromodulation Device Market Dynamics

2.5.1 Non-invasive Neuromodulation Device Market Trends

2.5.2 Non-invasive Neuromodulation Device Market Drivers

2.5.3 Non-invasive Neuromodulation Device Market Challenges

2.5.4 Non-invasive Neuromodulation Device Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top Non-invasive Neuromodulation Device Manufacturers by Sales (2017-2022)

3.1.1 Global Non-invasive Neuromodulation Device Sales by Manufacturers (2017-2022)

3.1.2 Global Non-invasive Neuromodulation Device Sales Market Share by Manufacturers (2017-2022)

3.1.3 Global 5 and 10 Largest Manufacturers by Non-invasive Neuromodulation Device Sales in 2021

3.2 Global Top Manufacturers Non-invasive Neuromodulation Device by Revenue

3.2.1 Global Non-invasive Neuromodulation Device Revenue by Manufacturers (2017-2022)

3.2.2 Top Non-invasive Neuromodulation Device Manufacturers Covered: Ranking by Revenue

3.2.3 Global Non-invasive Neuromodulation Device Revenue Share by Manufacturers (2017-2022)

3.2.4 Global Non-invasive Neuromodulation Device Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-invasive Neuromodulation Device as of 2021)

3.4 Global Non-invasive Neuromodulation Device Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Non-invasive Neuromodulation Device Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Non-invasive Neuromodulation Device Market

3.7 Key Manufacturers Non-invasive Neuromodulation Device Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Non-invasive Neuromodulation Device Market Size by Type

4.1 Global Non-invasive Neuromodulation Device Historic Market Review by Type (2017-2022)

4.1.1 Global Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2022)

4.1.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2022)

4.1.3 Non-invasive Neuromodulation Device Price by Type (2017-2022)

4.2 Global Non-invasive Neuromodulation Device Market Estimates and Forecasts by Type (2023-2028)

4.2.1 Global Non-invasive Neuromodulation Device Sales Forecast by Type (2023-2028)

4.2.2 Global Non-invasive Neuromodulation Device Revenue Forecast by Type (2023-2028)

4.2.3 Non-invasive Neuromodulation Device Price Forecast by Type (2023-2028)

5 Global Non-invasive Neuromodulation Device Market Size by Application

5.1 Global Non-invasive Neuromodulation Device Historic Market Review by Application (2017-2022)

5.1.1 Global Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2022)

5.1.2 Global Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2022)

5.1.3 Non-invasive Neuromodulation Device Price by Application (2017-2022)

5.2 Global Non-invasive Neuromodulation Device Market Estimates and Forecasts by Application (2023-2028)

5.2.1 Global Non-invasive Neuromodulation Device Sales Forecast by Application (2023-2028)

5.2.2 Global Non-invasive Neuromodulation Device Revenue Forecast by Application (2023-2028)

5.2.3 Non-invasive Neuromodulation Device Price Forecast by Application (2023-2028)

6 North America

6.1 North America Non-invasive Neuromodulation Device Sales Breakdown by Company

6.1.1 North America Non-invasive Neuromodulation Device Sales by Company (2017-2022)

6.1.2 North America Non-invasive Neuromodulation Device Revenue by Company (2017-2022)

6.2 North America Non-invasive Neuromodulation Device Market Size by Type

6.2.1 North America Non-invasive Neuromodulation Device Sales by Type (2017-2028)

6.2.2 North America Non-invasive Neuromodulation Device Revenue by Type (2017-2028)

6.3 North America Non-invasive Neuromodulation Device Market Size by Application

6.3.1 North America Non-invasive Neuromodulation Device Sales by Application (2017-2028)

6.3.2 North America Non-invasive Neuromodulation Device Revenue by Application (2017-2028)

6.4 North America Non-invasive Neuromodulation Device Market Size by Country

6.4.1 North America Non-invasive Neuromodulation Device Sales by Country (2017-2028)

6.4.2 North America Non-invasive Neuromodulation Device Revenue by Country (2017-2028)

6.4.3 United States

6.4.4 Canada

7 Europe

7.1 Europe Non-invasive Neuromodulation Device Sales Breakdown by Company

7.1.1 Europe Non-invasive Neuromodulation Device Sales by Company (2017-2022)

7.1.2 Europe Non-invasive Neuromodulation Device Revenue by Company (2017-2022)

7.2 Europe Non-invasive Neuromodulation Device Market Size by Type

7.2.1 Europe Non-invasive Neuromodulation Device Sales by Type (2017-2028)

7.2.2 Europe Non-invasive Neuromodulation Device Revenue by Type (2017-2028)

7.3 Europe Non-invasive Neuromodulation Device Market Size by Application

7.3.1 Europe Non-invasive Neuromodulation Device Sales by Application (2017-2028)

7.3.2 Europe Non-invasive Neuromodulation Device Revenue by Application (2017-2028)

7.4 Europe Non-invasive Neuromodulation Device Market Size by Country

7.4.1 Europe Non-invasive Neuromodulation Device Sales by Country (2017-2028)

7.4.2 Europe Non-invasive Neuromodulation Device Revenue by Country (2017-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific Non-invasive Neuromodulation Device Sales Breakdown by Company

8.1.1 Asia Pacific Non-invasive Neuromodulation Device Sales by Company (2017-2022)

8.1.2 Asia Pacific Non-invasive Neuromodulation Device Revenue by Company (2017-2022)

8.2 Asia Pacific Non-invasive Neuromodulation Device Market Size by Type

8.2.1 Asia Pacific Non-invasive Neuromodulation Device Sales by Type (2017-2028)

8.2.2 Asia Pacific Non-invasive Neuromodulation Device Revenue by Type (2017-2028)

8.3 Asia Pacific Non-invasive Neuromodulation Device Market Size by Application

8.3.1 Asia Pacific Non-invasive Neuromodulation Device Sales by Application (2017-2028)

8.3.2 Asia Pacific Non-invasive Neuromodulation Device Revenue by Application (2017-2028)

8.4 Asia Pacific Non-invasive Neuromodulation Device Market Size by Region

8.4.1 Asia Pacific Non-invasive Neuromodulation Device Sales by Region

8.4.2 Asia Pacific Non-invasive Neuromodulation Device Revenue by Region

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 China Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

9 Latin America

9.1 Latin America Non-invasive Neuromodulation Device Sales Breakdown by Company

9.1.1 Latin America Non-invasive Neuromodulation Device Sales by Company (2017-2022)

9.1.2 Latin America Non-invasive Neuromodulation Device Revenue by Company (2017-2022)

9.2 Latin America Non-invasive Neuromodulation Device Market Size by Type

9.2.1 Latin America Non-invasive Neuromodulation Device Sales by Type (2017-2028)

9.2.2 Latin America Non-invasive Neuromodulation Device Revenue by Type (2017-2028)

9.3 Latin America Non-invasive Neuromodulation Device Market Size by Application

9.3.1 Latin America Non-invasive Neuromodulation Device Sales by Application (2017-2028)

9.3.2 Latin America Non-invasive Neuromodulation Device Revenue by Application (2017-2028)

9.4 Latin America Non-invasive Neuromodulation Device Market Size by Country

9.4.1 Latin America Non-invasive Neuromodulation Device Sales by Country (2017-2028)

9.4.2 Latin America Non-invasive Neuromodulation Device Revenue by Country (2017-2028)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Non-invasive Neuromodulation Device Sales Breakdown by Company

10.1.1 Middle East and Africa Non-invasive Neuromodulation Device Sales by Company (2017-2022)

10.1.2 Middle East and Africa Non-invasive Neuromodulation Device Revenue by Company (2017-2022)

10.2 Middle East and Africa Non-invasive Neuromodulation Device Market Size by Type

10.2.1 Middle East and Africa Non-invasive Neuromodulation Device Sales by Type (2017-2028)

10.2.2 Middle East and Africa Non-invasive Neuromodulation Device Revenue by Type (2017-2028)

10.3 Middle East and Africa Non-invasive Neuromodulation Device Market Size by Application

10.3.1 Middle East and Africa Non-invasive Neuromodulation Device Sales by Application (2017-2028)

10.3.2 Middle East and Africa Non-invasive Neuromodulation Device Revenue by Application (2017-2028)

10.4 Middle East and Africa Non-invasive Neuromodulation Device Market Size by Country

10.4.1 Middle East and Africa Non-invasive Neuromodulation Device Sales by Country (2017-2028)

10.4.2 Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country (2017-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Company Profiles

11.1 Neuroelectrics

11.1.1 Neuroelectrics Corporation Information

11.1.2 Neuroelectrics Overview

11.1.3 Neuroelectrics Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.1.4 Neuroelectrics Non-invasive Neuromodulation Device Products and Services

11.1.5 Neuroelectrics Non-invasive Neuromodulation Device SWOT Analysis

11.1.6 Neuroelectrics Recent Developments

11.2 Magstim

11.2.1 Magstim Corporation Information

11.2.2 Magstim Overview

11.2.3 Magstim Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.2.4 Magstim Non-invasive Neuromodulation Device Products and Services

11.2.5 Magstim Non-invasive Neuromodulation Device SWOT Analysis

11.2.6 Magstim Recent Developments

11.3 NeuroCare Group

11.3.1 NeuroCare Group Corporation Information

11.3.2 NeuroCare Group Overview

11.3.3 NeuroCare Group Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.3.4 NeuroCare Group Non-invasive Neuromodulation Device Products and Services

11.3.5 NeuroCare Group Non-invasive Neuromodulation Device SWOT Analysis

11.3.6 NeuroCare Group Recent Developments

11.4 Soterix Medical

11.4.1 Soterix Medical Corporation Information

11.4.2 Soterix Medical Overview

11.4.3 Soterix Medical Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.4.4 Soterix Medical Non-invasive Neuromodulation Device Products and Services

11.4.5 Soterix Medical Non-invasive Neuromodulation Device SWOT Analysis

11.4.6 Soterix Medical Recent Developments

11.5 Newronika

11.5.1 Newronika Corporation Information

11.5.2 Newronika Overview

11.5.3 Newronika Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.5.4 Newronika Non-invasive Neuromodulation Device Products and Services

11.5.5 Newronika Non-invasive Neuromodulation Device SWOT Analysis

11.5.6 Newronika Recent Developments

11.6 Rogue Resolutions

11.6.1 Rogue Resolutions Corporation Information

11.6.2 Rogue Resolutions Overview

11.6.3 Rogue Resolutions Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.6.4 Rogue Resolutions Non-invasive Neuromodulation Device Products and Services

11.6.5 Rogue Resolutions Non-invasive Neuromodulation Device SWOT Analysis

11.6.6 Rogue Resolutions Recent Developments

11.7 Medtronic

11.7.1 Medtronic Corporation Information

11.7.2 Medtronic Overview

11.7.3 Medtronic Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.7.4 Medtronic Non-invasive Neuromodulation Device Products and Services

11.7.5 Medtronic Non-invasive Neuromodulation Device SWOT Analysis

11.7.6 Medtronic Recent Developments

11.8 Philips Healthcare

11.8.1 Philips Healthcare Corporation Information

11.8.2 Philips Healthcare Overview

11.8.3 Philips Healthcare Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.8.4 Philips Healthcare Non-invasive Neuromodulation Device Products and Services

11.8.5 Philips Healthcare Non-invasive Neuromodulation Device SWOT Analysis

11.8.6 Philips Healthcare Recent Developments

11.9 Shenzhen Yingchi Technology

11.9.1 Shenzhen Yingchi Technology Corporation Information

11.9.2 Shenzhen Yingchi Technology Overview

11.9.3 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.9.4 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Products and Services

11.9.5 Shenzhen Yingchi Technology Non-invasive Neuromodulation Device SWOT Analysis

11.9.6 Shenzhen Yingchi Technology Recent Developments

11.10 Shenzhen Hanix United

11.10.1 Shenzhen Hanix United Corporation Information

11.10.2 Shenzhen Hanix United Overview

11.10.3 Shenzhen Hanix United Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.10.4 Shenzhen Hanix United Non-invasive Neuromodulation Device Products and Services

11.10.5 Shenzhen Hanix United Non-invasive Neuromodulation Device SWOT Analysis

11.10.6 Shenzhen Hanix United Recent Developments

11.11 Shanghai Qiankang Medical Care Company

11.11.1 Shanghai Qiankang Medical Care Company Corporation Information

11.11.2 Shanghai Qiankang Medical Care Company Overview

11.11.3 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.11.4 Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Products and Services

11.11.5 Shanghai Qiankang Medical Care Company Recent Developments

11.12 TCT Research

11.12.1 TCT Research Corporation Information

11.12.2 TCT Research Overview

11.12.3 TCT Research Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.12.4 TCT Research Non-invasive Neuromodulation Device Products and Services

11.12.5 TCT Research Recent Developments

11.13 EB Neuro SpA

11.13.1 EB Neuro SpA Corporation Information

11.13.2 EB Neuro SpA Overview

11.13.3 EB Neuro SpA Non-invasive Neuromodulation Device Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2017-2022)

11.13.4 EB Neuro SpA Non-invasive Neuromodulation Device Products and Services

11.13.5 EB Neuro SpA Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 Non-invasive Neuromodulation Device Value Chain Analysis

12.2 Non-invasive Neuromodulation Device Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Non-invasive Neuromodulation Device Production Mode & Process

12.4 Non-invasive Neuromodulation Device Sales and Marketing

12.4.1 Non-invasive Neuromodulation Device Sales Channels

12.4.2 Non-invasive Neuromodulation Device Distributors

12.5 Non-invasive Neuromodulation Device Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

FEATURED COMPANIES

Shenzhen Yingchi Technology

Shenzhen Hanix United

Shanghai Qiankang Medical Care Company

TCT Research

EB Neuro SpA

List of Tables

Table 1. Global Non-invasive Neuromodulation Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)

Table 2. Major Manufacturers of Transcranial Direct Current Stimulation (tDCS)

Table 3. Major Manufacturers of Transcranial Alternating Current Stimulation (tACS)

Table 4. Major Manufacturers of Transcranial Pulsed Current Stimulation (tPCS)

Table 5. Major Manufacturers of Transcranial Random Noise Stimulation (tRNS)

Table 6. Major Manufacturers of Electroconvulsive therapy (ECT)

Table 7. Major Manufacturers of Others

Table 8. Global Non-invasive Neuromodulation Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)

Table 9. Global Non-invasive Neuromodulation Device Market Size (US$ Million) by Region: 2017 VS 2021 VS 2028

Table 10. Global Non-invasive Neuromodulation Device Sales by Region (2017-2022) & (K Units)

Table 11. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2017-2022)

Table 12. Global Non-invasive Neuromodulation Device Revenue by Region (2017-2022) & (US$ Million)

Table 13. Global Non-invasive Neuromodulation Device Revenue Market Share by Region (2017-2022)

Table 14. Global Non-invasive Neuromodulation Device Sales Forecast by Region (2023-2028) & (K Units)

Table 15. Global Non-invasive Neuromodulation Device Sales Market Share Forecast by Region (2023-2028)

Table 16. Global Non-invasive Neuromodulation Device Revenue Forecast by Region (2023-2028) & (US$ Million)

Table 17. Global Non-invasive Neuromodulation Device Revenue Market Share Forecast by Region (2023-2028)

Table 18. Top Non-invasive Neuromodulation Device Regions (Countries) Ranking by Market Size (US$ Million) in 2021

Table 19. Non-invasive Neuromodulation Device Market Trends

Table 20. Non-invasive Neuromodulation Device Market Drivers

Table 21. Non-invasive Neuromodulation Device Market Challenges

Table 22. Non-invasive Neuromodulation Device Market Restraints

Table 23. Global Non-invasive Neuromodulation Device Sales by Manufacturers (2017-2022) & (K Units)

Table 24. Global Non-invasive Neuromodulation Device Sales Share by Manufacturers (2017-2022)

Table 25. Global Non-invasive Neuromodulation Device Revenue by Manufacturers (2017-2022) & (US$ Million)

Table 26. Ranking of Global Top Non-invasive Neuromodulation Device Manufacturers by Revenue (US$ Million) in 2021

Table 27. Non-invasive Neuromodulation Device Revenue Share by Manufacturers (2017-2022)

Table 28. Global Non-invasive Neuromodulation Device Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 29. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Non-invasive Neuromodulation Device as of 2021)

Table 30. Key Manufacturers Non-invasive Neuromodulation Device Average Selling Price (ASP) & (2017-2022) & (US$/Unit)

Table 31. Key Manufacturers Non-invasive Neuromodulation Device Plants/Factories Distribution

Table 32. Key Manufacturers Non-invasive Neuromodulation Device Area Served

Table 33. Date of Key Manufacturers Enter into Non-invasive Neuromodulation Device Market

Table 34. Key Manufacturers Non-invasive Neuromodulation Device Product Type

Table 35. Mergers & Acquisitions, Expansion Plans

Table 36. Global Non-invasive Neuromodulation Device Sales (K Units) by Type (2017-2022)

Table 37. Global Non-invasive Neuromodulation Device Sales Share by Type (2017-2022)

Table 38. Global Non-invasive Neuromodulation Device Revenue (US$ Million) Market Share by Type (2017-2022)

Table 39. Global Non-invasive Neuromodulation Device Price (K Units) by Type (2017-2022)

Table 40. Global Non-invasive Neuromodulation Device Sales (K Units) by Type (2023-2028)

Table 41. Global Non-invasive Neuromodulation Device Sales Share by Type (2023-2028)

Table 42. Global Non-invasive Neuromodulation Device Revenue (US$ Million) Market Share by Type (2023-2028)

Table 43. Global Non-invasive Neuromodulation Device Revenue Share by Type (2023-2028)

Table 44. Global Non-invasive Neuromodulation Device Price (K Units) by Type (2023-2028)

Table 45. Global Non-invasive Neuromodulation Device Sales (K Units) by Application (2017-2022)

Table 46. Global Non-invasive Neuromodulation Device Sales Share by Application (2017-2022)

Table 47. Global Non-invasive Neuromodulation Device Revenue (US$ Million) Market Share by Application (2017-2022)

Table 48. Global Non-invasive Neuromodulation Device Price (K Units) by Application (2017-2022)

Table 49. Global Non-invasive Neuromodulation Device Sales (K Units) by Application (2023-2028)

Table 50. Global Non-invasive Neuromodulation Device Sales Share by Application (2023-2028)

Table 51. Global Non-invasive Neuromodulation Device Revenue (US$ Million) Market Share by Application (2023-2028)

Table 52. Global Non-invasive Neuromodulation Device Revenue Share by Application (2023-2028)

Table 53. Global Non-invasive Neuromodulation Device Price (K Units) by Application (2023-2028)

Table 54. North America Non-invasive Neuromodulation Device Sales by Company (2017-2022) & (K Units)

Table 55. North America Non-invasive Neuromodulation Device Sales Market Share by Company (2017-2022)

Table 56. North America Non-invasive Neuromodulation Device Revenue by Company (2017-2022) & (US$ Million)

Table 57. North America Non-invasive Neuromodulation Device Revenue Market Share by Company (2017-2022)

Table 58. North America Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)

Table 59. North America Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)

Table 60. North America Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (US$ Million)

Table 61. North America Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (US$ Million)

Table 62. North America Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)

Table 63. North America Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)

Table 64. North America Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (US$ Million)

Table 65. North America Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (US$ Million)

Table 66. North America Non-invasive Neuromodulation Device Sales by Country (2017-2022) & (K Units)

Table 67. North America Non-invasive Neuromodulation Device Sales by Country (2023-2028) & (K Units)

Table 68. North America Non-invasive Neuromodulation Device Revenue by Country (2017-2022) & (US$ Million)

Table 69. North America Non-invasive Neuromodulation Device Revenue by Country (2023-2028) & (US$ Million)

Table 70. Europe Non-invasive Neuromodulation Device Sales by Company (2017-2022) & (K Units)

Table 71. Europe Non-invasive Neuromodulation Device Sales Market Share by Company (2017-2022)

Table 72. Europe Non-invasive Neuromodulation Device Revenue by Company (2017-2022) & (US$ Million)

Table 73. Europe Non-invasive Neuromodulation Device Revenue Market Share by Company (2017-2022)

Table 74. Europe Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)

Table 75. Europe Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)

Table 76. Europe Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (US$ Million)

Table 77. Europe Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (US$ Million)

Table 78. Europe Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)

Table 79. Europe Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)

Table 80. Europe Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (US$ Million)

Table 81. Europe Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (US$ Million)

Table 82. Europe Non-invasive Neuromodulation Device Sales by Country (2017-2022) & (K Units)

Table 83. Europe Non-invasive Neuromodulation Device Sales by Country (2023-2028) & (K Units)

Table 84. Europe Non-invasive Neuromodulation Device Revenue by Country (2017-2022) & (US$ Million)

Table 85. Europe Non-invasive Neuromodulation Device Revenue by Country (2023-2028) & (US$ Million)

Table 86. Asia Pacific Non-invasive Neuromodulation Device Sales by Company (2017-2022) & (K Units)

Table 87. Asia Pacific Non-invasive Neuromodulation Device Sales Market Share by Company (2017-2022)

Table 88. Asia Pacific Non-invasive Neuromodulation Device Revenue by Company (2017-2022) & (US$ Million)

Table 89. Asia Pacific Non-invasive Neuromodulation Device Revenue Market Share by Company (2017-2022)

Table 90. Asia Pacific Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)

Table 91. Asia Pacific Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)

Table 92. Asia Pacific Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (US$ Million)

Table 93. Asia Pacific Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (US$ Million)

Table 94. Asia Pacific Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)

Table 95. Asia Pacific Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)

Table 96. Asia Pacific Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (US$ Million)

Table 97. Asia Pacific Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (US$ Million)

Table 98. Asia Pacific Non-invasive Neuromodulation Device Sales by Region (2017-2022) & (K Units)

Table 99. Asia Pacific Non-invasive Neuromodulation Device Sales by Region (2023-2028) & (K Units)

Table 100. Asia Pacific Non-invasive Neuromodulation Device Revenue by Region (2017-2022) & (US$ Million)

Table 101. Asia Pacific Non-invasive Neuromodulation Device Revenue by Region (2023-2028) & (US$ Million)

Table 102. Latin America Non-invasive Neuromodulation Device Sales by Company (2017-2022) & (K Units)

Table 103. Latin America Non-invasive Neuromodulation Device Sales Market Share by Company (2017-2022)

Table 104. Latin America Non-invasive Neuromodulation Device Revenue by Company (2017-2022) & (US$ Million)

Table 105. Latin America Non-invasive Neuromodulation Device Revenue Market Share by Company (2017-2022)

Table 106. Latin America Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)

Table 107. Latin America Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)

Table 108. Latin America Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (US$ Million)

Table 109. Latin America Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (US$ Million)

Table 110. Latin America Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)

Table 111. Latin America Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)

Table 112. Latin America Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (US$ Million)

Table 113. Latin America Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (US$ Million)

Table 114. Latin America Non-invasive Neuromodulation Device Sales by Country (2017-2022) & (K Units)

Table 115. Latin America Non-invasive Neuromodulation Device Sales by Country (2023-2028) & (K Units)

Table 116. Latin America Non-invasive Neuromodulation Device Revenue by Country (2017-2022) & (US$ Million)

Table 117. Latin America Non-invasive Neuromodulation Device Revenue by Country (2023-2028) & (US$ Million)

Table 118. Middle East and Africa Non-invasive Neuromodulation Device Sales by Company (2017-2022) & (K Units)

Table 119. Middle East and Africa Non-invasive Neuromodulation Device Sales Market Share by Company (2017-2022)

Table 120. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Company (2017-2022) & (US$ Million)

Table 121. Middle East and Africa Non-invasive Neuromodulation Device Revenue Market Share by Company (2017-2022)

Table 122. Middle East and Africa Non-invasive Neuromodulation Device Sales by Type (2017-2022) & (K Units)

Table 123. Middle East and Africa Non-invasive Neuromodulation Device Sales by Type (2023-2028) & (K Units)

Table 124. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Type (2017-2022) & (US$ Million)

Table 125. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Type (2023-2028) & (US$ Million)

Table 126. Middle East and Africa Non-invasive Neuromodulation Device Sales by Application (2017-2022) & (K Units)

Table 127. Middle East and Africa Non-invasive Neuromodulation Device Sales by Application (2023-2028) & (K Units)

Table 128. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Application (2017-2022) & (US$ Million)

Table 129. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Application (2023-2028) & (US$ Million)

Table 130. Middle East and Africa Non-invasive Neuromodulation Device Sales by Country (2017-2022) & (K Units)

Table 131. Middle East and Africa Non-invasive Neuromodulation Device Sales by Country (2023-2028) & (K Units)

Table 132. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country (2017-2022) & (US$ Million)

Table 133. Middle East and Africa Non-invasive Neuromodulation Device Revenue by Country (2023-2028) & (US$ Million)

Table 134. Neuroelectrics Corporation Information

Table 135. Neuroelectrics Description and Overview

Table 136. Neuroelectrics Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 137. Neuroelectrics Non-invasive Neuromodulation Device Product and Services

Table 138. Neuroelectrics Non-invasive Neuromodulation Device SWOT Analysis

Table 139. Neuroelectrics Recent Developments

Table 140. Magstim Corporation Information

Table 141. Magstim Description and Overview

Table 142. Magstim Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 143. Magstim Non-invasive Neuromodulation Device Product and Services

Table 144. Magstim Non-invasive Neuromodulation Device SWOT Analysis

Table 145. Magstim Recent Developments

Table 146. NeuroCare Group Corporation Information

Table 147. NeuroCare Group Description and Overview

Table 148. NeuroCare Group Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 149. NeuroCare Group Non-invasive Neuromodulation Device Product and Services

Table 150. NeuroCare Group Non-invasive Neuromodulation Device SWOT Analysis

Table 151. NeuroCare Group Recent Developments

Table 152. Soterix Medical Corporation Information

Table 153. Soterix Medical Description and Overview

Table 154. Soterix Medical Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 155. Soterix Medical Non-invasive Neuromodulation Device Product and Services

Table 156. Soterix Medical Non-invasive Neuromodulation Device SWOT Analysis

Table 157. Soterix Medical Recent Developments

Table 158. Newronika Corporation Information

Table 159. Newronika Description and Overview

Table 160. Newronika Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 161. Newronika Non-invasive Neuromodulation Device Product and Services

Table 162. Newronika Non-invasive Neuromodulation Device SWOT Analysis

Table 163. Newronika Recent Developments

Table 164. Rogue Resolutions Corporation Information

Table 165. Rogue Resolutions Description and Overview

Table 166. Rogue Resolutions Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 167. Rogue Resolutions Non-invasive Neuromodulation Device Product and Services

Table 168. Rogue Resolutions Non-invasive Neuromodulation Device SWOT Analysis

Table 169. Rogue Resolutions Recent Developments

Table 170. Medtronic Corporation Information

Table 171. Medtronic Description and Overview

Table 172. Medtronic Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 173. Medtronic Non-invasive Neuromodulation Device Product and Services

Table 174. Medtronic Non-invasive Neuromodulation Device SWOT Analysis

Table 175. Medtronic Recent Developments

Table 176. Philips Healthcare Corporation Information

Table 177. Philips Healthcare Description and Overview

Table 178. Philips Healthcare Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 179. Philips Healthcare Non-invasive Neuromodulation Device Product and Services

Table 180. Philips Healthcare Non-invasive Neuromodulation Device SWOT Analysis

Table 181. Philips Healthcare Recent Developments

Table 182. Shenzhen Yingchi Technology Corporation Information

Table 183. Shenzhen Yingchi Technology Description and Overview

Table 184. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 185. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device Product and Services

Table 186. Shenzhen Yingchi Technology Non-invasive Neuromodulation Device SWOT Analysis

Table 187. Shenzhen Yingchi Technology Recent Developments

Table 188. Shenzhen Hanix United Corporation Information

Table 189. Shenzhen Hanix United Description and Overview

Table 190. Shenzhen Hanix United Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 191. Shenzhen Hanix United Non-invasive Neuromodulation Device Product and Services

Table 192. Shenzhen Hanix United Non-invasive Neuromodulation Device SWOT Analysis

Table 193. Shenzhen Hanix United Recent Developments

Table 194. Shanghai Qiankang Medical Care Company Corporation Information

Table 195. Shanghai Qiankang Medical Care Company Description and Overview

Table 196. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 197. Shanghai Qiankang Medical Care Company Non-invasive Neuromodulation Device Product and Services

Table 198. Shanghai Qiankang Medical Care Company Recent Developments

Table 199. TCT Research Corporation Information

Table 200. TCT Research Description and Overview

Table 201. TCT Research Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 202. TCT Research Non-invasive Neuromodulation Device Product and Services

Table 203. TCT Research Recent Developments

Table 204. EB Neuro SpA Corporation Information

Table 205. EB Neuro SpA Description and Overview

Table 206. EB Neuro SpA Non-invasive Neuromodulation Device Sales (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2017-2022)

Table 207. EB Neuro SpA Non-invasive Neuromodulation Device Product and Services

Table 208. EB Neuro SpA Recent Developments

Table 209. Key Raw Materials Lists

Table 210. Raw Materials Key Suppliers Lists

Table 211. Non-invasive Neuromodulation Device Distributors List

Table 212. Non-invasive Neuromodulation Device Customers List

Table 213. Research Programs/Design for This Report

Table 214. Key Data Information from Secondary Sources

Table 215. Key Data Information from Primary Sources

List of Figures

Figure 1. Non-invasive Neuromodulation Device Product Picture

Figure 2. Global Non-invasive Neuromodulation Device Sales Market Share by Type in 2021 & 2028

Figure 3. Transcranial Direct Current Stimulation (tDCS) Product Picture

Figure 4. Transcranial Alternating Current Stimulation (tACS) Product Picture

Figure 5. Transcranial Pulsed Current Stimulation (tPCS) Product Picture

Figure 6. Transcranial Random Noise Stimulation (tRNS) Product Picture

Figure 7. Electroconvulsive therapy (ECT) Product Picture

Figure 8. Others Product Picture

Figure 9. Global Non-invasive Neuromodulation Device Sales Market Share by Application in 2021 & 2028

Figure 10. Hospital Use Case

Figure 11. Clinic Use Case

Figure 12. Others Use Case

Figure 13. Non-invasive Neuromodulation Device Report Years Considered

Figure 14. Global Non-invasive Neuromodulation Device Revenue, (US$ Million), 2017 VS 2021 VS 2028

Figure 15. Global Non-invasive Neuromodulation Device Market Size 2017-2028 (US$ Million)

Figure 16. Global Non-invasive Neuromodulation Device Sales (2017-2022) & (K Units)

Figure 17. Global Non-invasive Neuromodulation Device Market Size Market Share by Region: 2021 VS 2028

Figure 18. Global Non-invasive Neuromodulation Device Sales Market Share by Region (2017-2022)

Figure 19. Global Non-invasive Neuromodulation Device Sales Market Share by Region in 2021

Figure 20. Global Non-invasive Neuromodulation Device Revenue Market Share by Region in 2017 VS 2021

Figure 21. Global Non-invasive Neuromodulation Device Sales Share by Manufacturers in 2021

Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Non-invasive Neuromodulation Device Sales in 2021

Figure 23. Non-invasive Neuromodulation Device Revenue Share by Manufacturers in 2021

Figure 24. Non-invasive Neuromodulation Device Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021

Figure 25. Global Non-invasive Neuromodulation Device Revenue Share by Type (2017-2022)

Figure 26. Global Non-invasive Neuromodulation Device Revenue Growth Rate by Type in 2017 & 2021

Figure 27. Global Non-invasive Neuromodulation Device Revenue Share by Application (2017-2022)

Figure 28. Global Non-invasive Neuromodulation Device Revenue Growth Rate by Application in 2017 & 2021

Figure 29. North America Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)

Figure 30. North America Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)

Figure 31. North America Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)

Figure 32. North America Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)

Figure 33. North America Non-invasive Neuromodulation Device Sales Share by Country (2017-2028)

Figure 34. North America Non-invasive Neuromodulation Device Revenue Share by Country (2017-2028)

Figure 35. United States Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 36. Canada Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 37. Europe Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)

Figure 38. Europe Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)

Figure 39. Europe Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)

Figure 40. Europe Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)

Figure 41. Europe Non-invasive Neuromodulation Device Sales Share by Country (2017-2028)

Figure 42. Europe Non-invasive Neuromodulation Device Revenue Share by Country (2017-2028)

Figure 43. Germany Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 44. France Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 45. U.K. Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 46. Italy Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 47. Russia Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 48. Asia Pacific Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)

Figure 49. Asia Pacific Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)

Figure 50. Asia Pacific Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)

Figure 51. Asia Pacific Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)

Figure 52. Asia Pacific Non-invasive Neuromodulation Device Sales Share by Region (2017-2028)

Figure 53. Asia Pacific Non-invasive Neuromodulation Device Revenue Share by Region (2017-2028)

Figure 54. China Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 55. Japan Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 56. South Korea Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 57. India Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 58. Australia Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 59. China Taiwan Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 60. Indonesia Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 61. Thailand Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 62. Malaysia Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 63. Latin America Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)

Figure 64. Latin America Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)

Figure 65. Latin America Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)

Figure 66. Latin America Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)

Figure 67. Latin America Non-invasive Neuromodulation Device Sales Share by Country (2017-2028)

Figure 68. Latin America Non-invasive Neuromodulation Device Revenue Share by Country (2017-2028)

Figure 69. Mexico Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 70. Brazil Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 71. Argentina Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 72. Middle East and Africa Non-invasive Neuromodulation Device Sales Market Share by Type (2017-2028)

Figure 73. Middle East and Africa Non-invasive Neuromodulation Device Revenue Market Share by Type (2017-2028)

Figure 74. Middle East and Africa Non-invasive Neuromodulation Device Sales Market Share by Application (2017-2028)

Figure 75. Middle East and Africa Non-invasive Neuromodulation Device Revenue Market Share by Application (2017-2028)

Figure 76. Middle East and Africa Non-invasive Neuromodulation Device Sales Share by Country (2017-2028)

Figure 77. Middle East and Africa Non-invasive Neuromodulation Device Revenue Share by Country (2017-2028)

Figure 78. Turkey Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 79. Saudi Arabia Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 80. UAE Non-invasive Neuromodulation Device Revenue (2017-2028) & (US$ Million)

Figure 81. Non-invasive Neuromodulation Device Value Chain

Figure 82. Non-invasive Neuromodulation Device Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$5600

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$8400

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$11200

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Non-invasive Neuromodulation Device Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

Published Date: January 2023

Report Code: QYRE-Auto-9L8360

Global Non-invasive Neuromodulation Device Industry Research Report, Growth Trends and Competitive Analysis 2022-2028

FEATURED COMPANIES

Non-invasive Neuromodulation Device Segment by Type

Non-invasive Neuromodulation Device Segment by Application

FEATURED COMPANIES

RELATED REPORTS